Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Oracle is racing to reinvent itself as an AI-enabled cloud platform, funding AI infrastructure with debt while juggli...
Uber reports record cash flow and a bold autonomous-vehicle push as investors wonder if the uber stock price predicti...
Investors are keen on Ingevity (NGVT) 2026 earnings as the company reports Q1 results. This article breaks down the n...
A closer look at stealthgas (gass) 2026 earnings reveals how fleet utilization, charter rates, and debt shape this ga...
Palantir has moved from hero to a pullback phase. This guide breaks down what its valuation says about the future, wi...
Meta leans on ad-driven growth and in-house AI monetization to push margins higher, while Intel navigates heavy capex...
When two tech giants sit in the same valuation neighborhood, smart investors focus on the details. This guide breaks ...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
A surge in XRP trading on key exchanges has investors buzzing. This sign that better could point to shifting sentimen...
A public rebuke of management sparks a wave of worker stories about the price of speaking up at work and how it affec...
Aster DEX unveiled a sweeping tokenomics upgrade that channels almost all daily fees into automatic ASTER buybacks, s...